Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...